Company profile: GeneThera
1.1 - Company Overview
Company description
- Provider of biotechnology applying molecular technologies to improve food safety and eradicate zoonotic diseases, including Johne's Disease, Mad Cow Disease, Chronic Wasting Disease, and E.coli, affecting terrestrial, avian, and aquatic animals.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to GeneThera
Twist Bioscience
HQ: United States
Website
- Description: Provider of synthetic DNA solutions using a semiconductor-based platform for high-throughput, cost-effective manufacturing; customizable gene synthesis; variant libraries; NGS target enrichment panels for viral genome detection and characterization; synthetic RNA controls for diagnostic quality assurance; antibody development against SARS-CoV-2; and comprehensive viral research panels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Twist Bioscience company profile →
Arrakis Therapeutics
HQ: United States
Website
- Description: Provider of RNA-targeted drug discovery tools and small-molecule therapeutics, including the rSM Toolkit to identify RNA substructures, Direct Modulators that bind RNA, Targeted RNA Degraders, and Covalent Modifiers that block translation. Maintains pipeline programs for cancer, cardiovascular conditions, neurodegeneration, and rare diseases, including an rSM program for DM1.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arrakis Therapeutics company profile →
Diagnovus
HQ: United States
Website
- Description: Provider of innovative molecular diagnostics delivering individualized genetic information to better inform physicians, patients, and families facing difficult disease prospects, improving patient health and the quality of treatment decisions; founded in 2011 and based in Nashville, TN.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnovus company profile →
NorthGene
HQ: United Kingdom
Website
- Description: Provider of medical testing, health care and other services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NorthGene company profile →
RealTime Laboratories
HQ: United States
Website
- Description: Provider of the only U.S. CAP- and CLIA-accredited clinical mycotoxin testing, with comprehensive panels for indoor mold-related mycotoxins; at-home specimen collection kits; complimentary physician and patient navigator consultations to explain results; environmental pollutant profile testing; and glyphosate exposure analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RealTime Laboratories company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for GeneThera
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to GeneThera
2.2 - Growth funds investing in similar companies to GeneThera
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for GeneThera
4.2 - Public trading comparable groups for GeneThera
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →